• MRTFA-KCNMB1 Axis Regulates Cancer Cell Stiffness and Metast

  2026-06-18

  Gajda et al. identify the MRTFA-KCNMB1 signaling axis as a key regulator of cancer cell stiffness, revealing that modulation of potassium channel activity influences metastatic colonization and immune evasion. Their integrated genetic and pharmacological approach highlights new therapeutic possibilities for targeting biophysical properties of tumor cells.

• MEG3 Modulates TGF-β1/PI3K/AKT Axis in NiO NP-Induced Fibros

  2026-06-17

  This study reveals how lncRNA MEG3 inhibits pulmonary fibrosis caused by nickel oxide nanoparticles (NiO NPs) through regulation of the TGF-β1-mediated PI3K/AKT pathway. The findings provide new mechanistic insight into nanoparticle-induced fibrogenesis and highlight points of pharmacological intervention for anti-fibrotic research.

• 3X (DYKDDDDK) Peptide: Precision Epitope Tagging for Structu

  2026-06-17

  Discover how the 3X (DYKDDDDK) Peptide advances protein science through superior epitope tagging and crystallography applications. This article uniquely explores the mechanistic and structural implications for sensitive protein detection and purification workflows.

• MVC-Induced RhoA/ROCK1/MLC2 Activation Disrupts Tight Juncti

  2026-06-16

  This study uncovers how the Minute Virus of Canines (MVC) activates the RhoA/ROCK1/MLC2 pathway, leading to tight junction dissociation and facilitating viral entry by exposing Occludin as a co-receptor. The work delivers mechanistic insights valuable for developing targeted antiviral strategies and informs the application of RhoA inhibitors in dissecting virus-host interactions.

• L-Phenylephrine: A Systems Biology Lens on α1A Agonist Resea

  2026-06-16

  Explore L-Phenylephrine as a selective adrenergic α1A receptor agonist, focusing on its systems-level impact in cardiovascular and neural models. Uniquely, this article integrates mechanistic, transcriptional, and sex-specific insights for advanced research design.

• LY2109761: Advanced Smad2/3 Pathway Modulation in Disease Mo

  2026-06-15

  Explore how LY2109761, a potent TGF-β receptor type I and II dual inhibitor, enables unprecedented control of Smad2/3 phosphorylation in diverse disease models. This article delivers new insights into mechanism-based selectivity, practical assay design, and translational relevance beyond prior reviews.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-06-15

  A recent study reveals that targeting the epigenetic regulator DOT1L reprograms innate immunity and significantly enhances the anti-myeloma efficacy of lenalidomide. These findings highlight DOT1L as a promising therapeutic target and provide mechanistic insight into overcoming immunotherapy resistance in multiple myeloma.

• 4-Phenylbutyric Acid: ER Stress Modulator for Cell Death Stu

  2026-06-14

  4-Phenylbutyric acid (4-PBA) is a validated chemical chaperone that alleviates endoplasmic reticulum (ER) stress and modulates cell death pathways. APExBIO’s high-purity 4-PBA offers reproducible performance in apoptosis, autophagy, and nephrotoxicity models. Recent evidence supports its role in dissecting ER stress mechanisms in kidney injury and beyond.

• Pam3CSK4 TFA: Precision Activation of TLR1/2 in Translationa

  2026-06-13

  Discover how Pam3CSK4 TFA, a high-purity TLR1/2 agonist, enables unparalleled precision in dissecting innate immune responses and cytokine profiling. This in-depth article explores advanced experimental strategies, key findings from recent research, and practical assay guidance for immune signaling studies.

• Tioconazole in Research: Decoding Fungal Membrane Vulnerabil

  2026-06-12

  Explore how Tioconazole, a leading antifungal medication, is driving advanced research on fungal membrane vulnerabilities and ergosterol biosynthesis. This article uniquely links molecular mechanisms to practical assay optimization, offering a perspective not found in existing literature.

• Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) in

  2026-06-12

  Harnessing Apigenin’s dual HDAC inhibition and neuroprotective actions, researchers can deploy streamlined protocols for malignant mesothelioma models and Alzheimer’s disease assays. This guide details practical workflows, troubleshooting insights, and experimental parameters to maximize translational impact using APExBIO’s high-purity Apigenin.

• Senolytic Sensitization in Melanoma: Defining Effective Comb

  2026-06-11

  This study systematically investigates how different therapies induce senescence and senolytic sensitivity in human melanoma cells. By dissecting the molecular and phenotypic responses to genotoxic and targeted treatments, the authors clarify which combinations best promote selective elimination of senescent tumor cells, informing future strategies to reduce resistance and relapse.

• Dorsomorphin (Compound C): Precision Tools for AMPK Pathway

  2026-06-11

  Dorsomorphin (Compound C) stands out as a dual AMPK and BMP pathway inhibitor, enabling high-fidelity manipulation of metabolic, autophagic, and differentiation processes in cellular and animal models. Its validated selectivity and robust performance empower researchers to dissect complex signaling with reproducibility and clarity.

• Pam3CSK4: Precision TLR1/2 Agonist for Inflammation Models

  2026-06-10

  Pam3CSK4 is a synthetic TLR1/2 agonist enabling precise immune cell activation and modeling of inflammatory pathways. Its use facilitates robust, reproducible modulation of macrophage nitric oxide production and Th1/Th2 balance in allergic airway inflammation models.

• Curcumin Inhibits NLRP3-Mediated Pyroptosis in Endothelial C

  2026-06-10

  This study demonstrates that curcumin protects human umbilical vein endothelial cells (HUVECs) from hydrogen peroxide-induced pyroptosis by inhibiting NLRP3 inflammasome activation. The findings clarify curcumin's anti-inflammatory mechanism and suggest new therapeutic approaches for atherosclerosis and related vascular inflammatory diseases.

16181 records 1/1079 page Next 12345 下5页 Last page